| Title |
Economic aspects of bladder cancer: what are the benefits and costs?
|
|---|---|
| Published in |
World Journal of Urology, March 2009
|
| DOI | 10.1007/s00345-009-0395-z |
| Pubmed ID | |
| Authors |
K. D. Sievert, B. Amend, U. Nagele, D. Schilling, J. Bedke, M. Horstmann, J. Hennenlotter, S. Kruck, A. Stenzl |
| Abstract |
Bladder cancer (BC) has the highest lifetime treatment costs per patient of all cancers. The high recurrence rate and ongoing invasive monitoring requirement are the key contributors to the economic and human toll of this disease. The purpose of this paper was to utilize the recent literature to identify opportunities for improving the benefits and costs of BC care. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 43% |
| Bosnia and Herzegovina | 1 | 14% |
| Guinea | 1 | 14% |
| Unknown | 2 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 325 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Austria | 1 | <1% |
| Brazil | 1 | <1% |
| Portugal | 1 | <1% |
| India | 1 | <1% |
| South Africa | 1 | <1% |
| Spain | 1 | <1% |
| Peru | 1 | <1% |
| Unknown | 316 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 55 | 17% |
| Student > Ph. D. Student | 48 | 15% |
| Student > Bachelor | 36 | 11% |
| Student > Master | 32 | 10% |
| Other | 23 | 7% |
| Other | 67 | 21% |
| Unknown | 64 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 103 | 32% |
| Biochemistry, Genetics and Molecular Biology | 35 | 11% |
| Agricultural and Biological Sciences | 34 | 10% |
| Engineering | 25 | 8% |
| Immunology and Microbiology | 8 | 2% |
| Other | 41 | 13% |
| Unknown | 79 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 542. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2020.
All research outputs
#38,759
of 23,517,535 outputs
Outputs from World Journal of Urology
#2
of 2,160 outputs
Outputs of similar age
#48
of 94,686 outputs
Outputs of similar age from World Journal of Urology
#1
of 8 outputs
Altmetric has tracked 23,517,535 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,160 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,686 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them